Dilatation of the basilar artery in response to selective activation of endothelin B receptors in vivo

Takanari Kitazono, D. D. Heistad, F. M. Faraci

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The objective of this study was to examine effects of activation of endothelin (ET) B receptors on tone of the basilar artery in vivo. By using a cranial window in anesthetized rats, we examined the effects of IRL 1620, a selective ET(B) receptor agonist, on diameter of the basilar artery. Under control conditions, diameter of the basilar artery was 214 ± 6 μm (mean ± S.E.). Topical application of IRL 1620 (10-6 mol/l) for 4 min dilated the basilar artery by 30 ± 4%. Marked desensitization of vasodilator responses was observed in response to a second application of IRL 1620, but not acetylcholine, which indicates a homologous nature of desensitization. REA/001, an ET(A)/ET(B) receptor antagonist, abolished IRL 1620-induced dilatation of the basilar artery. BQ 123, a selective ET(A) receptor antagonist, inhibited constriction in response to ET-1, but did not affect dilator responses of the basilar artery to IRL 1620. Both N(G)-nitro-L- arginine methyl ester and N(G)-nitro-L-arginine, inhibitors of nitric oxide synthase, produced marked inhibition of dilator responses of the basilar artery to IRL 1620 without inhibiting vasodilator responses to sodium nitroprusside. Indomethacin did not inhibit vasodilatation in response to IRL 1620. These findings suggest that activation of ET(B) receptors produces dilatation of the basilar artery in vivo. Dilator responses of the basilar artery to activation of ET(B) receptors are dependent on production of nitric oxide.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume273
Issue number1
Publication statusPublished - Jan 1 1995
Externally publishedYes

Fingerprint

Endothelin B Receptors
Basilar Artery
Dilatation
Vasodilator Agents
Endothelins
NG-Nitroarginine Methyl Ester
Nitroprusside
Endothelin-1
IRL 1620
Constriction
Vasodilation
Nitric Oxide Synthase
Indomethacin
Acetylcholine
Arginine
Nitric Oxide

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Dilatation of the basilar artery in response to selective activation of endothelin B receptors in vivo. / Kitazono, Takanari; Heistad, D. D.; Faraci, F. M.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 273, No. 1, 01.01.1995, p. 1-6.

Research output: Contribution to journalArticle

@article{e67a52ad46d54f1ebcd67c08203abb69,
title = "Dilatation of the basilar artery in response to selective activation of endothelin B receptors in vivo",
abstract = "The objective of this study was to examine effects of activation of endothelin (ET) B receptors on tone of the basilar artery in vivo. By using a cranial window in anesthetized rats, we examined the effects of IRL 1620, a selective ET(B) receptor agonist, on diameter of the basilar artery. Under control conditions, diameter of the basilar artery was 214 ± 6 μm (mean ± S.E.). Topical application of IRL 1620 (10-6 mol/l) for 4 min dilated the basilar artery by 30 ± 4{\%}. Marked desensitization of vasodilator responses was observed in response to a second application of IRL 1620, but not acetylcholine, which indicates a homologous nature of desensitization. REA/001, an ET(A)/ET(B) receptor antagonist, abolished IRL 1620-induced dilatation of the basilar artery. BQ 123, a selective ET(A) receptor antagonist, inhibited constriction in response to ET-1, but did not affect dilator responses of the basilar artery to IRL 1620. Both N(G)-nitro-L- arginine methyl ester and N(G)-nitro-L-arginine, inhibitors of nitric oxide synthase, produced marked inhibition of dilator responses of the basilar artery to IRL 1620 without inhibiting vasodilator responses to sodium nitroprusside. Indomethacin did not inhibit vasodilatation in response to IRL 1620. These findings suggest that activation of ET(B) receptors produces dilatation of the basilar artery in vivo. Dilator responses of the basilar artery to activation of ET(B) receptors are dependent on production of nitric oxide.",
author = "Takanari Kitazono and Heistad, {D. D.} and Faraci, {F. M.}",
year = "1995",
month = "1",
day = "1",
language = "English",
volume = "273",
pages = "1--6",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Dilatation of the basilar artery in response to selective activation of endothelin B receptors in vivo

AU - Kitazono, Takanari

AU - Heistad, D. D.

AU - Faraci, F. M.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The objective of this study was to examine effects of activation of endothelin (ET) B receptors on tone of the basilar artery in vivo. By using a cranial window in anesthetized rats, we examined the effects of IRL 1620, a selective ET(B) receptor agonist, on diameter of the basilar artery. Under control conditions, diameter of the basilar artery was 214 ± 6 μm (mean ± S.E.). Topical application of IRL 1620 (10-6 mol/l) for 4 min dilated the basilar artery by 30 ± 4%. Marked desensitization of vasodilator responses was observed in response to a second application of IRL 1620, but not acetylcholine, which indicates a homologous nature of desensitization. REA/001, an ET(A)/ET(B) receptor antagonist, abolished IRL 1620-induced dilatation of the basilar artery. BQ 123, a selective ET(A) receptor antagonist, inhibited constriction in response to ET-1, but did not affect dilator responses of the basilar artery to IRL 1620. Both N(G)-nitro-L- arginine methyl ester and N(G)-nitro-L-arginine, inhibitors of nitric oxide synthase, produced marked inhibition of dilator responses of the basilar artery to IRL 1620 without inhibiting vasodilator responses to sodium nitroprusside. Indomethacin did not inhibit vasodilatation in response to IRL 1620. These findings suggest that activation of ET(B) receptors produces dilatation of the basilar artery in vivo. Dilator responses of the basilar artery to activation of ET(B) receptors are dependent on production of nitric oxide.

AB - The objective of this study was to examine effects of activation of endothelin (ET) B receptors on tone of the basilar artery in vivo. By using a cranial window in anesthetized rats, we examined the effects of IRL 1620, a selective ET(B) receptor agonist, on diameter of the basilar artery. Under control conditions, diameter of the basilar artery was 214 ± 6 μm (mean ± S.E.). Topical application of IRL 1620 (10-6 mol/l) for 4 min dilated the basilar artery by 30 ± 4%. Marked desensitization of vasodilator responses was observed in response to a second application of IRL 1620, but not acetylcholine, which indicates a homologous nature of desensitization. REA/001, an ET(A)/ET(B) receptor antagonist, abolished IRL 1620-induced dilatation of the basilar artery. BQ 123, a selective ET(A) receptor antagonist, inhibited constriction in response to ET-1, but did not affect dilator responses of the basilar artery to IRL 1620. Both N(G)-nitro-L- arginine methyl ester and N(G)-nitro-L-arginine, inhibitors of nitric oxide synthase, produced marked inhibition of dilator responses of the basilar artery to IRL 1620 without inhibiting vasodilator responses to sodium nitroprusside. Indomethacin did not inhibit vasodilatation in response to IRL 1620. These findings suggest that activation of ET(B) receptors produces dilatation of the basilar artery in vivo. Dilator responses of the basilar artery to activation of ET(B) receptors are dependent on production of nitric oxide.

UR - http://www.scopus.com/inward/record.url?scp=0028958375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028958375&partnerID=8YFLogxK

M3 - Article

VL - 273

SP - 1

EP - 6

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -